Susquehanna International Group’s Lantern Pharma LTRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-14,949
Closed -$52.9K 6874
2025
Q1
$52.9K Sell
14,949
-11,352
-43% -$40.2K ﹤0.01% 6003
2024
Q4
$83.9K Buy
26,301
+4,420
+20% +$14.1K ﹤0.01% 5740
2024
Q3
$80.3K Sell
21,881
-37,878
-63% -$139K ﹤0.01% 5182
2024
Q2
$279K Buy
59,759
+33,975
+132% +$159K ﹤0.01% 4309
2024
Q1
$227K Buy
+25,784
New +$227K ﹤0.01% 4543
2023
Q3
Sell
-10,581
Closed -$59.7K 6014
2023
Q2
$59.7K Buy
+10,581
New +$59.7K ﹤0.01% 5166
2022
Q4
Sell
-14,558
Closed -$70K 6381
2022
Q3
$70K Buy
+14,558
New +$70K ﹤0.01% 5406
2022
Q1
Sell
-10,439
Closed -$83K 6201
2021
Q4
$83K Sell
10,439
-470
-4% -$3.74K ﹤0.01% 5346
2021
Q3
$122K Buy
+10,909
New +$122K ﹤0.01% 4915
2021
Q2
Hold
0
5678
2021
Q1
Hold
0
5511